ProfileGDS4459 / ENSG00000099341
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 88% 74% 94% 85% 88% 76% 93% 92% 91% 92% 82% 93% 92% 83% 93% 88% 74% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 16.8888
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 25.4474
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 38.1394
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 46.385
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 57.0488
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 65.776
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 77.7393
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 87.6592
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 97.5791
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 107.5792
GSM623474group B, liver allograft wedge biopsie placebo treatment 16.3782
GSM623475group B, liver allograft wedge biopsie placebo treatment 27.9693
GSM623476group B, liver allograft wedge biopsie placebo treatment 37.5792
GSM623477group B, liver allograft wedge biopsie placebo treatment 46.283
GSM623478group B, liver allograft wedge biopsie placebo treatment 57.9293
GSM623479group B, liver allograft wedge biopsie placebo treatment 66.8688
GSM623480group B, liver allograft wedge biopsie placebo treatment 75.4474